{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:49:44Z","timestamp":1780433384101,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jtcvs.2014.09.047","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T16:29:40Z","timestamp":1411057780000},"page":"378-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The 4E-BP1\/eIF4E ratio is a determinant for rapamycin response in esophageal cancer cells"],"prefix":"10.1016","volume":"149","author":[{"given":"Han-Shui","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hua","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2014.09.047_bib1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jtcvs.2007.11.007","article-title":"Reduced membranous \u03b2-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus","volume":"135","author":"Hsu","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.critrevonc.2014.01.010","article-title":"Targeted therapies in metastatic esophageal cancer: advances over the past decade","volume":"91","author":"Mohamed","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib3","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signalling pathway in human cancer","volume":"13","author":"Populo","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/bjc.2012.36","article-title":"Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on esophageal squamous cell carcinoma","volume":"106","author":"Hirashima","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib6","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.4161\/cc.10.22.18124","article-title":"High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1","volume":"10","author":"Yellen","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1146\/annurev.biochem.68.1.913","article-title":"eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation","volume":"68","author":"Gingras","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2004.05.024","article-title":"Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells","volume":"5","author":"Avdulov","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib9","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1038\/sj.onc.1207545","article-title":"eIF-4E expression and its role in malignancies and metastases","volume":"23","author":"De Benedetti","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib10","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1245\/s10434-010-1428-y","article-title":"MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus","volume":"18","author":"Hsu","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.bjc.6603353","article-title":"Predicted mechanisms of resistance to mTOR inhibitors","volume":"95","author":"Kurmasheva","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib12","doi-asserted-by":"crossref","first-page":"13907","DOI":"10.1074\/jbc.M110782200","article-title":"4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin","volume":"277","author":"Dilling","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib13","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-12-2395","article-title":"eIF4E\/4E-BP ratio predicts the efficacy of mTOR targeted therapies","volume":"72","author":"Alain","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/1078-0432.CCR-03-0043","article-title":"Determinants of rapamycin sensitivity in breast cancer cells","volume":"10","author":"Noh","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.canlet.2007.01.026","article-title":"An activated mTOR\/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR","volume":"253","author":"Hou","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/07357909409024867","article-title":"Expression of multiple oncogenes in human esophageal carcinomas","volume":"12","author":"Wong","year":"1994","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib17","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/cncr.25599","article-title":"Chemo-resistance of lung cancer stem-like cells depends on activation of Hsp27","volume":"117","author":"Hsu","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0076-6879(07)31007-0","article-title":"Methods for studying signal-dependent regulation of translation factor activity","volume":"431","author":"Wang","year":"2007","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.canlet.2009.05.031","article-title":"Rapamycin increases the p53\/MDM2 protein ratio and p53-dependent apoptosis by translational inhibition of mdm2 in cancer cells","volume":"286","author":"Kao","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib20","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/jcb.24557","article-title":"The matricellular protein CCN1 suppresses lung cancer cell growth by inducing senescence via the p53\/p21 pathway","volume":"114","author":"Leu","year":"2013","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib21","doi-asserted-by":"crossref","first-page":"C281","DOI":"10.1152\/ajpcell.00422.2003","article-title":"G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K\/AKT\/mTOR\/p70S6K1 signaling in human ovarian cancer cells","volume":"287","author":"Gao","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0955-0674(98)80150-6","article-title":"The mRNA 5\u2032 cap-binding protein eIF4E and control of cell growth","volume":"10","author":"Sonenberg","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib23","doi-asserted-by":"crossref","first-page":"18859","DOI":"10.1074\/jbc.M211696200","article-title":"ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1","volume":"278","author":"Rolli-Derkinderen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.clinbiochem.2005.11.007","article-title":"Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer","volume":"39","author":"Salehi","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib25","doi-asserted-by":"crossref","first-page":"e29136","DOI":"10.1371\/journal.pone.0029136","article-title":"Sensitivity of global translation to mTOR inhibition in REN cells depends on the equilibrium between eIF4E and 4E-BP1","volume":"6","author":"Grosso","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib26","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1371\/journal.pone.0000242","article-title":"Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation","volume":"2","author":"Mamane","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib27","first-page":"3895","article-title":"Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells","volume":"56","author":"Seufferlein","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00240-002-0282-1","article-title":"Rapamycin induces Smad activity in prostate cancer cell lines","volume":"30","author":"van der Poel","year":"2003","journal-title":"Urol Res"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib29","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1158\/1078-0432.CCR-08-2336","article-title":"Phosphorylated 4E-BP1 is associated with poor survival in melanoma","volume":"15","author":"O\u2019Reilly","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ccr.2010.05.023","article-title":"4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors","volume":"18","author":"She","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/35074516","article-title":"ERK induces p35, a neuron-specific activator of cdk5, through induction of egr-1","volume":"3","author":"Harada","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4161\/cbt.2.6.671","article-title":"Egr-1 signaling in prostate cancer","volume":"2","author":"Adamson","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jjco\/hyp120","article-title":"Phase I clinical and pharmacokinetic study of RAD001 (Everolimus) administered daily to Japanese patients with advanced solid tumors","volume":"40","author":"Okamoto","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2014.09.047_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cam4.77","article-title":"Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma","volume":"2","author":"Werner","year":"2013","journal-title":"Cancer Med"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522314013117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522314013117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:54:31Z","timestamp":1758387271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522314013117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0022522314013117"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2014.09.047","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 4E-BP1\/eIF4E ratio is a determinant for rapamycin response in esophageal cancer cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2014.09.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}